By Joseph Erunke
ABUJA – THE National Agency for Food And Drug Administration And Control, NAFDAC, has denied approving Paxherbal for the treatment of symptoms associated with COVID-19.
The agency, in a statement, Saturday, by its Director-General, Prof. Mojisola Adeyeye, insisted reports “circulating in the social media that NAFDAC has approved Paxherbal product “specifically for treating symptoms associated with Coronavirus” is wrong and inaccurate.”
“Paxherbal applied for Listing of Pax Herbal Cugzin capsule 290mg which was approved by NAFDAC and Listed as “Safe to use”.
“The applicant claimed that it is an immune booster and an anti-infective.
” However, as part of the labelling of the product, and in line with global practice, a Disclaimer is on the product label which clearly states that the claims have not been evaluated by NAFDAC.
“Therefore, the statements circulating in the social media that NAFDAC has approved Paxherbal product “specifically…
Source: Vanguard Newspaper